Integral Current Deferred Revenue from 2010 to 2024
IDX Stock | 2.91 0.01 0.34% |
Current Deferred Revenue | First Reported 2010-12-31 | Previous Quarter 1.5 M | Current Value 1.5 M | Quarterly Volatility 8.7 M |
Check Integral Diagnostics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Integral Diagnostics' main balance sheet or income statement drivers, such as Interest Expense of 23.4 M, Total Revenue of 238.8 M or Operating Income of 5.1 M, as well as many indicators such as . Integral financial statements analysis is a perfect complement when working with Integral Diagnostics Valuation or Volatility modules.
Integral | Current Deferred Revenue |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Integral Stock Analysis
When running Integral Diagnostics' price analysis, check to measure Integral Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Integral Diagnostics is operating at the current time. Most of Integral Diagnostics' value examination focuses on studying past and present price action to predict the probability of Integral Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Integral Diagnostics' price. Additionally, you may evaluate how the addition of Integral Diagnostics to your portfolios can decrease your overall portfolio volatility.